Perraton, Matthew Thomas

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Perraton, Matthew Thomas's trades of Theralase Technologies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
225.47
Quantity 89,251 +20.8%
Value CA$423,709
Transaction date
Purchase
Price
394.70
Quantity 57,685 -30.1%
Value CA$39,474
Transaction date
Purchase
Price
241.97
Quantity 50,956
Value CA$1,457,221
Transaction date
Purchase
Price
0.20
Quantity 51,200 +56.3%
Value CA$10,240
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-25 2026-08-24
B Purchase
89,251 +20.8%
225.47
CA$423,709 		89,251 +20.8% 225.47 CA$423,709
2026-05-20 2026-05-20
B Purchase
57,685 -30.1%
394.70
CA$39,474 		57,685 -30.1% 394.70 CA$39,474
2026-04-10 2026-04-10
B Purchase
50,956
241.97
CA$1,457,221 		50,956 241.97 CA$1,457,221
2025-06-17 2025-06-17
B Purchase
51,200 +56.3%
0.20
CA$10,240 		51,200 +56.3% 0.20 CA$10,240
2025-03-12 2025-03-11
S Sale
40,000
0.30
CA$12,000 		40,000 0.30 CA$12,000